BTG Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BTG Plc with three other
pharmaceutical manufacturers in Europe:
sales of 604.21 million Euro [US$683.50 million]
(£755.36 million [US$975.91 million]
based in France
(789.60 million Euro [US$893.21 million]
BTG Plc reported sales of £620.50 million (US$801.68 million)
March of 2018.
increase of 8.8%
versus 2017, when the company's sales were £570.50 million.
Sales at BTG Plc have increased during each of the previous five years
(and since 2013, sales have increased a total of 166%).
Sales of Interventional Medicine saw an increase
12.3% in 2018, from
£216.20 million to £242.90 million.